Chlamydia Rapid Test Device (Swab/Urine)

Call For Pricing.

Model Number: NH-31419

Brand: Niche Healthcare

The Chlamydia Ranid Test Device is a manid chromatogranhic immunoassay for the aualitativedetection of Chlamydia trachomatis in clinical specimens to aid in the diagnosis of Chlamydiahen.

 

Description

Catalog No. CHL-6012 Format Device
Specimen Swab/Urine Certificate None CE
Reading Time 10 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Composition Individually packed test devices, Reagent A, Package insert, Workstation, Extraction tubes & tips, Reagent B, Sterilized swabs

 

The Chlamydia Rapid Test Device (Swab/Urine) can offer several healthcare benefits in the National Health Service (NHS) or any healthcare system. Here are potential benefits:

  1. Early Detection of Chlamydia Infection: The rapid test allows for the early detection of Chlamydia trachomatis infection in swab samples or urine, enabling timely diagnosis and treatment.

  2. Prompt Initiation of Treatment: Early detection facilitates the prompt initiation of antibiotic treatment for individuals with chlamydia, preventing the progression of the infection and reducing the risk of complications such as pelvic inflammatory disease (PID) and infertility.

  3. Prevention of Transmission: Identifying individuals with chlamydia allows for the implementation of measures to prevent the spread of the infection, especially in high-risk populations. This includes counseling on safe sex practices and partner notification.

  4. Screening High-Risk Populations: Rapid tests are valuable for screening high-risk populations, such as sexually active individuals, adolescents, and those with multiple sexual partners, to identify and treat asymptomatic cases.

  5. Resource Optimization: Rapid tests contribute to efficient resource utilization by providing quick and cost-effective diagnostic information, allowing healthcare providers to prioritize and manage chlamydia cases more effectively.

  6. Point-of-Care Testing: Rapid tests can be performed at the point of care, providing quick results without the need for sending samples to a laboratory. This expedites decision-making, allowing for immediate counseling and treatment initiation.

  7. Public Health Surveillance: Monitoring the prevalence of chlamydia infections in the population through rapid testing contributes to public health surveillance efforts. This information helps in planning and implementing preventive measures, including educational campaigns and targeted interventions.

  8. Reduction of Complications: Early detection and treatment of chlamydia contribute to reducing the risk of complications, such as PID, ectopic pregnancy, and infertility in women, as well as preventing urethritis and complications in men.

  9. Improved Sexual Health Management: Rapid testing supports sexual health management by providing timely information for healthcare providers to address chlamydia and other sexually transmitted infections (STIs) comprehensively.

  10. Reduced Stigma and Anxiety: Rapid testing may contribute to reducing the stigma and anxiety associated with chlamydia testing, as individuals can receive results quickly, enabling prompt counseling and support.

 

Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.

 

Types of Infections

Types of Infections

 

For more information, contact us 01274 965089 or check out our website at www.nicheofficesolutions.co.uk www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk 

Reviews

There are no reviews yet.

Be the first to review “Chlamydia Rapid Test Device (Swab/Urine)”